60 related articles for article (PubMed ID: 217114)
1. Morphologic and clinical aspects of estrogen receptors in carcinoma of the breast.
Kern WH
Surg Gynecol Obstet; 1979 Feb; 148(2):240-2. PubMed ID: 217114
[TBL] [Abstract][Full Text] [Related]
2. Estrogen receptor determination and long term survival of patients with carcinoma of the breast.
Crowe JP; Gordon NH; Hubay CA; Shenk RR; Zollinger RM; Brumberg DJ; McGuire WL; Shuck JM
Surg Gynecol Obstet; 1991 Oct; 173(4):273-8. PubMed ID: 1925896
[TBL] [Abstract][Full Text] [Related]
3. Should histologic type be taken into account when considering neoadjuvant chemotherapy in breast carcinoma?
Sullivan PS; Apple SK
Breast J; 2009; 15(2):146-54. PubMed ID: 19292800
[TBL] [Abstract][Full Text] [Related]
4. Primary breast cancer phenotypes associated with propensity for central nervous system metastases.
Tham YL; Sexton K; Kramer R; Hilsenbeck S; Elledge R
Cancer; 2006 Aug; 107(4):696-704. PubMed ID: 16826579
[TBL] [Abstract][Full Text] [Related]
5. Association of low nm23 RNA levels in human primary infiltrating ductal breast carcinomas with lymph node involvement and other histopathological indicators of high metastatic potential.
Bevilacqua G; Sobel ME; Liotta LA; Steeg PS
Cancer Res; 1989 Sep; 49(18):5185-90. PubMed ID: 2475243
[TBL] [Abstract][Full Text] [Related]
6. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.
Wei B; Wang J; Bourne P; Yang Q; Hicks D; Bu H; Tang P
Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor-negative, progesterone receptor-positive breast carcinoma: poor clinical outcome.
Keshgegian AA; Cnaan A
Arch Pathol Lab Med; 1996 Oct; 120(10):970-3. PubMed ID: 12046611
[TBL] [Abstract][Full Text] [Related]
8. Metastatic breast carcinoma in pleural fluid. Correlation of morphology with estrogen receptor activity and morphology of the primary carcinoma.
Wiley EL; Von Roenn J
Acta Cytol; 1990; 34(2):169-74. PubMed ID: 2321450
[TBL] [Abstract][Full Text] [Related]
9. Relationship between progesterone receptor, axillary node status and productive fibrosis in ductal infiltrating carcinoma of the breast.
Giani C; Campani D; De Negri F; Capotorti E; Savarese MR; Benigni G; Incensati RM; Breccia M; Miccoli P; Evangelista G
Appl Pathol; 1989; 7(4):225-32. PubMed ID: 2553078
[TBL] [Abstract][Full Text] [Related]
10. Luteinizing hormone receptor status and clinical, pathologic, and prognostic features in patients with breast carcinomas.
Meduri G; Charnaux N; Spyratos F; Hacene K; Loosfelt H; Milgrom E
Cancer; 2003 Apr; 97(7):1810-6. PubMed ID: 12655539
[TBL] [Abstract][Full Text] [Related]
11. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of proliferation associated nucleolar antigen P120 in human breast carcinoma.
Freeman JW; McGrath P; Bondada V; Selliah N; Ownby H; Maloney T; Busch RK; Busch H
Cancer Res; 1991 Apr; 51(8):1973-8. PubMed ID: 1672621
[TBL] [Abstract][Full Text] [Related]
13. Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.
Fisher B; Slack N; Katrych D; Wolmark N
Surg Gynecol Obstet; 1975 Apr; 140(4):528-34. PubMed ID: 805475
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
15. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
16. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
de Candia P; Akram M; Benezra R; Brogi E
Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptors in ductal carcinoma in situ of breast.
Malafa M; Chaudhuri B; Thomford NR; Chaudhuri PK
Am Surg; 1990 Jul; 56(7):436-9. PubMed ID: 2164337
[TBL] [Abstract][Full Text] [Related]
18. [Steroid hormone receptors in mammary carcinoma. Immunohistochemical detection and prognostic significance].
Reiner A; Neumeister B; Reiner G; Jakesz R; Kolb R; Schemper M; Spona J
Zentralbl Pathol; 1991; 137(3):233-41. PubMed ID: 1657132
[TBL] [Abstract][Full Text] [Related]
19. Breast carcinomas with protein S-100 immunoreactivity. An immunocytochemical and ultrastructural study.
Lunde S; Nesland JM; Holm R; Johannessen JV
Pathol Res Pract; 1987 Oct; 182(5):627-31. PubMed ID: 2825146
[TBL] [Abstract][Full Text] [Related]
20. [Expression and intranuclear distribution of nucleolin in estrogen receptor-negative and estrogen receptor-positive breast cancers in women measured by laser scanning cytometry].
Masiuk M
Ann Acad Med Stetin; 2006; 52(2):23-32. PubMed ID: 17633394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
